Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Inks $25M Credit Facility Agreement

NEW YORK (GenomeWeb News) – Caliper Life Sciences has restructured a credit facility agreement with Silicon Valley Bank allowing Caliper to borrow up to $25 million through revolving loan advances including as much as $5 million in letters of credit.  

According to a filing Thursday with the US Securities and Exchange Commission, Caliper plans to use the capital to fund ongoing operations and working capital needs. The agreement amends and restates a credit facility and loan Caliper received from SVB in 2006.

The facility, which matures on June 30, 2009, allows Caliper to borrow as much as $25 million as long as it maintains at least that much in unrestricted cash with SVB.

The facility also includes conditions related to payment defaults, as well as covenants related to the liquidity and earnings levels that Caliper must maintain at the end of each quarter.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.